A drug that prevents the transmission of the HIV virus will be available in England from April, the Department of Health has confirmed. PrEP - or pre-exposure prophylaxis - is an antiretroviral medicine which, taken once a day, stops the transmission of HIV during unprotected sex. The pill is already available in Scotland and Wales to people at risk of contracting the virus. It is estimated there are about 103,800 people living with HIV in the UK. Health Secretary Matt Hancock said the roll-out of the drug in England would eliminate new HIV infections within 10 years. NHS England will pay for the drug. The cost is estimated to likely be much less than the lifetime bill for treating those who already carry the virus. The Terrence Higgins Trust, a charity that supports those living with HIV, estimates that about 7% of the roughly 103,800 people living with the virus in the UK do not know they are HIV positive. Ian Green, Chief Executive at the Terrence Higgins Trust, described ...
Architects of the UK's nuanced approach: Sir Patrick Vallance (left) and Prof Chris Whitty (right) More than 200 scientists have written to the government urging them to introduce tougher measures to tackle the spread of Covid-19. In an open letter, the 229 specialists in disciplines ranging from mathematics to genetics - though no leading experts in the science of the spread of diseases - say the UK's current approach will put the NHS under additional stress and "risk many more lives than necessary". The signatories also criticised comments made by Sir Patrick Vallance, the government's chief scientific adviser, about managing the spread of the infection to make the population immune. The Department of Health said Sir Patrick's comments had been misinterpreted. The scientists - all from UK universities - also questioned the government's view that people would become fed up with restrictions if they were imposed too soon. Their letter was published ...